Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shima Rafie (Pune, India), Shima Rafiei, Subhabrata Moitra, Bill Brashier, Sundeep Salvi, Sadhu Naik, Mohan Kulkarni. Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD. Eur Respir J 2015; 46: Suppl. 59, 523

Member's Comments

No comment yet.

Related content which might interest you: Elevated serum levels of oxidized low-density lipoprotein in COPD patients Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Intermediate and severe α1-antitrypsin deficiency: influence on plasma α1-antitrypsin, FEV1 and risk of COPD. Three meta-anlyses Source: Eur Respir J 2002; 20: Suppl. 38, 513s Year: 2002 COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Low bronchial NO flux, but not low FENO, predicts pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Exercise tolerance is related to lung density in patients with COPD Source: Annual Congress 2011 - Lung and airway function Year: 2011 Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006 Total desmosines in plasma and urine correlate with lung function Source: Eur Respir J 2012; 39: 839-845 Year: 2012 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Leptin levels are associated with reduced lung function in men with COPD Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013